all press releases

  • 07/17/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc., today announced the product categories and supplier savings opportunities available as part of its Quarter 3 National Group Buys Program available July 1 through September 30, 2018. The National Group Buys program is one of several strategic programs from Vizient designed to deliver additional cost savings to its member hospitals. Siemens Healthineers, the featured supplier for Quarter 3, is offering savingsmore...
  • 07/16/18
    IRVING, Texas--(BUSINESS WIRE)--At a time when rising drug costs are putting an increasing strain on the bottom lines of Vizient member hospitals, we are supportive of efforts by the Administration to understand the complexities of the U.S. pharmaceutical market and look for solutions to curb rising drug costs. Vizient applauds the overall goal of the Department of Health and Human Services’ (HHS) Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs to increasemore...
  • 07/13/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. applauds the U.S. Food and Drug Administration (FDA) for forming a new drug shortages task force and advancing long-term solutions to prevent shortages. Stable and reliable supply, along with cost and safety, are always top priorities for Vizient. In addition to regular communication and education to our health care members, for years we’ve worked to mitigate the impact of shortages and price spikes throughmore...
  • 07/11/18
    IRVING, Texas--(BUSINESS WIRE)--Children who are hospitalized often require specialized devices and drug treatments that are appropriate for their smaller size. To assist providers with insights and education into the latest innovations and technology Vizient has published its latest edition of its Technology Watch series titled, “Emerging Pediatric Technologies”. The report highlights the development of new medical devices for the pediatric patient population, a groupmore...
  • 07/10/18
    IRVING, Texas--(BUSINESS WIRE)--Top oncology stakeholders from across the health care industry are set to meet this week at the MedCity CONVERGE event July 11-12 in Philadelphia. Steven Lucio, associate vice president, pharmacy services, at Vizient will be one of the featured panelists for the session, “Promising Drugs, Pricing and Access” which will focus on the impact of increasingly expensive, novel oncology therapies on the U.S. health care market. The panel willmore...
  • 07/02/18
    IRVING, Texas--(BUSINESS WIRE)--For many years, Vizient has been helping diverse suppliers refine their business strategy to more effectively compete, prosper, and grow within the health care supply chain. Today, the company announces it is expanding its support of diverse suppliers through a new agreement with the Initiative for a Competitive Inner City (ICIC) and their Inner City Capital Connections program (ICCC). The agreement is expected to have a direct impact onmore...
  • 06/26/18
    IRVING, Texas--(BUSINESS WIRE)--Suppliers interested in showcasing their innovative technology to clinicians nationwide are encouraged to act quickly to apply to participate in the 2018 Vizient Innovative Technology Exchange. The event will take place on Thursday, October 4, 2018, at the Wynn Hotel in Las Vegas as part of the 2018 Vizient Connection Summit. The deadline to apply is Friday, July 13, 2018. The 2018 Innovative Technology Exchange ismore...
  • 06/22/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient is deeply concerned that current tariffs set to go into effect on July 6, and any ensuing trade war, will have long term impacts on the cost of health care in the U.S., which is already at unsustainably high levels. Every day we work to ensure that patients have access to the best possible suppliers and services for first-rate medical care. That is why we are troubled to see that a 25% tariff will be placed on medical/more...
  • 06/15/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient applauds the recent decision by The Centers for Medicare and Medicaid Services to delay its update to the Overall Hospital Star Ratings that was planned for July. This decision by CMS is supported by data that Vizient provided to the Agency related to methodology issues that negatively affect hospital ratings. Vizient’s feedback to CMS focused on specific technical details identified in the July 2018 preview reports. Themore...
  • 06/13/18
    IRVING, Texas--(BUSINESS WIRE)--Vizient, Inc. today announced its support for the Stretching Entity Resources for Vulnerable (SERV) Communities Act. This newly proposed legislation would take a number of important steps to protect and preserve the integrity of the 340B Drug Pricing Program, which is essential for safety-net hospitals that provide critical health care services to vulnerable patients and underserved communities. The SERV Act wouldmore...